China NT Pharma Group Company Limited (HKG:1011)

HKG:1011 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	683	553	71	145	171	135
Market Cap Growth	394.34%	675.38%	-50.91%	-15.27%	26.76%	-40.83%
Enterprise Value	1,027	895	445	993	1,082	992
Last Close Price	0.72	0.82	0.27	0.55	0.90	0.71
Forward PE	-	15.33	15.33	15.33	15.33	15.33
PS Ratio	25.42	20.57	1.77	17.90	-	0.49
PB Ratio	-2.24	-1.81	-0.17	-0.39	-0.63	-0.52
P/FCF Ratio	-	-	-	3.32	4.78	-
P/OCF Ratio	-	-	-	2.61	4.19	-
EV/Sales Ratio	38.22	33.29	11.01	122.42	-	3.57
EV/FCF Ratio	-	-	-	22.69	30.19	-
Debt / Equity Ratio	-1.16	-1.16	-0.94	-1.02	-3.42	-3.94
Debt / FCF Ratio	-	-	-	8.68	26.06	-
Net Debt / Equity Ratio	-1.13	-1.13	-0.92	-1.01	-3.39	-3.89
Net Debt / EBITDA Ratio	-25.13	-25.13	-27.80	-6.65	-87.43	-14.36
Net Debt / FCF Ratio	-	-	-39.63	8.64	25.87	-6.05
Asset Turnover	0.07	0.07	0.11	0.01	-	0.20
Inventory Turnover	51.14	51.14	-	-	-	2.74
Quick Ratio	0.02	0.02	0.01	0.02	0.05	0.05
Current Ratio	0.03	0.03	0.02	0.02	0.06	0.30
Return on Assets (ROA)	-2.27%	-2.27%	-2.49%	-5.26%	-1.69%	-5.19%
Return on Invested Capital (ROIC)	-34.69%	-862.50%	-	-19.29%	-4.46%	-12.65%
Return on Capital Employed (ROCE)	4.50%	4.50%	3.40%	16.70%	16.20%	-157.40%
Earnings Yield	-4.24%	-5.24%	-79.63%	-108.91%	-43.79%	-135.74%
FCF Yield	-	-	-13.80%	30.14%	20.92%	-123.43%
Buyback Yield / Dilution	88.29%	88.29%	-10.72%	-25.59%	-0.51%	-0.14%
Total Shareholder Return	88.29%	88.29%	-10.72%	-25.59%	-0.51%	-0.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.